Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
3,148,074
-
Shares change
-
+3,148,074
-
Total reported value, excl. options
-
$45,702,000
-
Value change
-
+$45,701,982
-
Number of buys
-
39
-
Price
-
$14.53
Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) as of Q1 2021
As of 31 Mar 2021 Sensei Biotherapeutics, Inc. - COM (SNSE) had 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,148,074 shares of stock of the company.
Largest 10 holders included CITADEL ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., VANGUARD GROUP INC, Falcon Edge Capital, LP, JPMORGAN CHASE & CO, MOORE CAPITAL MANAGEMENT, LP, GEODE CAPITAL MANAGEMENT, LLC, Tudor Investment Corp Et Al, and Duquesne Family Office LLC.
This table shows 40 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.